| J9271 | Injection, pembrolizumab, 1 mg | 15,000 | $40 | $525K |
| J0897 | Injection, denosumab, 1 mg | 9,420 | $20 | $169.6K |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 3,440 | $40 | $120.4K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 740 | $100 | $70.7K |
| Q5107 | Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg | 2,770 | $20 | $63.7K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 300 | $110 | $31.4K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 190 | $160 | $30.3K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 200 | $140 | $27.7K |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 100 | $130 | $13.4K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 250 | $50 | $13.1K |